Sirona Biochem Corp Cash Flow Conversion Efficiency
Sirona Biochem Corp cash flow conversion efficiency. Based on the latest financial reports, Sirona Biochem Corp (SBM) has a cash flow conversion efficiency ratio of 0.160x as of July 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-552.59K ≈ $-399.74K USD) by net assets (CA$-3.46 Million ≈ $-2.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Sirona Biochem Corp (2011–2023)
Cash flow conversion efficiency of Sirona Biochem Corp from 2011 to 2023. This chart illustrates how Sirona Biochem Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SBM share price today for real-time trading data and today's change.
Sirona Biochem Corp Cash Flow Conversion Ratio Explained
Sirona Biochem Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Sirona Biochem Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sirona Biochem Corp ranked by their cash flow conversion efficiency. Also see market cap of Sirona Biochem Corp for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Reach Resources Ltd
AU:RR1
|
-0.032x |
|
Dycasa SA
BA:DYCA
|
-0.135x |
|
Legend Power Systems Inc
V:LPS
|
-1.789x |
|
Bayhorse Silver Inc
V:BHS
|
6.385x |
|
InnSuites Hospitality Trust
NYSE MKT:IHT
|
0.988x |
|
AUGA GROUP AB EO 029
F:W9Z
|
0.032x |
|
Dromeas SA
AT:DROME
|
0.020x |
|
SKK Holdings Limited
NASDAQ:SKK
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Sirona Biochem Corp (2011–2023)
The table below shows the annual cash flow conversion efficiency of Sirona Biochem Corp from 2011 to 2023. Review Sirona Biochem Corp free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-10-31 | CA$-2.51 Million ≈ $-1.82 Million |
CA$-1.76 Million ≈ $-1.27 Million |
0.700x | +106.89% |
| 2022-10-31 | CA$214.51K ≈ $155.18K |
CA$-2.18 Million ≈ $-1.58 Million |
-10.151x | -145.63% |
| 2021-10-31 | CA$-97.02K ≈ $-70.18K |
CA$-2.16 Million ≈ $-1.56 Million |
22.246x | +149.92% |
| 2020-10-31 | CA$47.40K ≈ $34.28K |
CA$-2.11 Million ≈ $-1.53 Million |
-44.564x | -2641.24% |
| 2019-10-31 | CA$2.19 Million ≈ $1.58 Million |
CA$-3.56 Million ≈ $-2.57 Million |
-1.626x | -719.47% |
| 2018-10-31 | CA$-2.26 Million ≈ $-1.64 Million |
CA$-593.35K ≈ $-429.22K |
0.262x | -78.57% |
| 2017-10-31 | CA$-2.04 Million ≈ $-1.48 Million |
CA$-2.50 Million ≈ $-1.81 Million |
1.225x | +191.01% |
| 2016-10-31 | CA$1.56 Million ≈ $1.13 Million |
CA$-2.10 Million ≈ $-1.52 Million |
-1.346x | +5.71% |
| 2015-10-31 | CA$2.15 Million ≈ $1.55 Million |
CA$-3.06 Million ≈ $-2.22 Million |
-1.427x | -37.36% |
| 2014-10-31 | CA$1.79 Million ≈ $1.30 Million |
CA$-1.86 Million ≈ $-1.35 Million |
-1.039x | +10.78% |
| 2013-10-31 | CA$2.15 Million ≈ $1.55 Million |
CA$-2.50 Million ≈ $-1.81 Million |
-1.164x | +7.70% |
| 2012-10-31 | CA$1.70 Million ≈ $1.23 Million |
CA$-2.15 Million ≈ $-1.55 Million |
-1.261x | -35.27% |
| 2011-10-31 | CA$2.72 Million ≈ $1.97 Million |
CA$-2.54 Million ≈ $-1.84 Million |
-0.933x | -- |
About Sirona Biochem Corp
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company … Read more